First patient dosed with Moderna’s coronavirus vaccine candidate
Earlier this week, we focused in on technologies around messenger RNA, or mRNA, as key players in the search for a coronavirus vaccine. More news on that front. In Massachusetts, Moderna disclosed that the first participant has been dosed in the Phase 1 study of the Company’s mRNA vaccine (mRNA-1273) against the novel coronavirus (SARS-CoV-2). […]









